The global market for Intravaginal Device was valued at US$ 3451 million in the year 2024 and is projected to reach a revised size of US$ 6918 million by 2031, growing at a CAGR of 10.6% during the forecast period.
An intravaginal device refers to any device that is inserted into the vagina for various purposes, including contraception, fertility monitoring, pelvic floor therapy, or the delivery of medications. These devices are designed to be safe and effective when used correctly and are typically made of medical-grade materials.Intravaginal Device 麻豆原创 Segmented By Contraceptive Devices, Urinary Incontinence Devices Product with Birth Control, STD, Stress Urinary Incontinence application
North American market for Intravaginal Device is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Intravaginal Device is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Intravaginal Device include Bioteque America Inc., Bray Group Limited., Gyneas, MedGyn Products, Inc., Panpac Medical Corp., Sugar International, Thomas Medical, CooperSurgical Inc., Bayer AG, Merck & Co., Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Intravaginal Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravaginal Device.
The Intravaginal Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intravaginal Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravaginal Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bioteque America Inc.
Bray Group Limited.
Gyneas
MedGyn Products, Inc.
Panpac Medical Corp.
Sugar International
Thomas Medical
CooperSurgical Inc.
Bayer AG
Merck & Co., Inc.
CIDR, LLC
AbbVie
Medicines360
Besins Healthcare
ContraMed
InControl Medical
INVO Bioscience
Segment by Type
Contraceptive Devices
Urinary Incontinence Devices
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centre
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravaginal Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravaginal Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Intravaginal Device 麻豆原创 Overview
1.1 Product Definition
1.2 Intravaginal Device by Type
1.2.1 Global Intravaginal Device 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Contraceptive Devices
1.2.3 Urinary Incontinence Devices
1.2.4 Others
1.3 Intravaginal Device by Application
1.3.1 Global Intravaginal Device 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centre
1.3.5 Others
1.4 Global Intravaginal Device 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Intravaginal Device Revenue 2020-2031
1.4.2 Global Intravaginal Device Sales 2020-2031
1.4.3 Global Intravaginal Device 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Intravaginal Device 麻豆原创 Competition by Manufacturers
2.1 Global Intravaginal Device Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Intravaginal Device Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Intravaginal Device Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Intravaginal Device, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intravaginal Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravaginal Device, Product Type & Application
2.7 Global Key Manufacturers of Intravaginal Device, Date of Enter into This Industry
2.8 Global Intravaginal Device 麻豆原创 Competitive Situation and Trends
2.8.1 Global Intravaginal Device 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Intravaginal Device Players 麻豆原创 Share by Revenue
2.8.3 Global Intravaginal Device 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Intravaginal Device 麻豆原创 Scenario by Region
3.1 Global Intravaginal Device 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Intravaginal Device Sales by Region: 2020-2031
3.2.1 Global Intravaginal Device Sales by Region: 2020-2025
3.2.2 Global Intravaginal Device Sales by Region: 2026-2031
3.3 Global Intravaginal Device Revenue by Region: 2020-2031
3.3.1 Global Intravaginal Device Revenue by Region: 2020-2025
3.3.2 Global Intravaginal Device Revenue by Region: 2026-2031
3.4 North America Intravaginal Device 麻豆原创 Facts & Figures by Country
3.4.1 North America Intravaginal Device 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Intravaginal Device Sales by Country (2020-2031)
3.4.3 North America Intravaginal Device Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Intravaginal Device 麻豆原创 Facts & Figures by Country
3.5.1 Europe Intravaginal Device 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Intravaginal Device Sales by Country (2020-2031)
3.5.3 Europe Intravaginal Device Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravaginal Device 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Intravaginal Device 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Intravaginal Device Sales by Region (2020-2031)
3.6.3 Asia Pacific Intravaginal Device Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Intravaginal Device 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Intravaginal Device 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Intravaginal Device Sales by Country (2020-2031)
3.7.3 Latin America Intravaginal Device Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravaginal Device 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Intravaginal Device 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Intravaginal Device Sales by Country (2020-2031)
3.8.3 Middle East and Africa Intravaginal Device Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Intravaginal Device Sales by Type (2020-2031)
4.1.1 Global Intravaginal Device Sales by Type (2020-2025)
4.1.2 Global Intravaginal Device Sales by Type (2026-2031)
4.1.3 Global Intravaginal Device Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Intravaginal Device Revenue by Type (2020-2031)
4.2.1 Global Intravaginal Device Revenue by Type (2020-2025)
4.2.2 Global Intravaginal Device Revenue by Type (2026-2031)
4.2.3 Global Intravaginal Device Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Intravaginal Device Price by Type (2020-2031)
5 Segment by Application
5.1 Global Intravaginal Device Sales by Application (2020-2031)
5.1.1 Global Intravaginal Device Sales by Application (2020-2025)
5.1.2 Global Intravaginal Device Sales by Application (2026-2031)
5.1.3 Global Intravaginal Device Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Intravaginal Device Revenue by Application (2020-2031)
5.2.1 Global Intravaginal Device Revenue by Application (2020-2025)
5.2.2 Global Intravaginal Device Revenue by Application (2026-2031)
5.2.3 Global Intravaginal Device Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Intravaginal Device Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bioteque America Inc.
6.1.1 Bioteque America Inc. Company Information
6.1.2 Bioteque America Inc. Description and Business Overview
6.1.3 Bioteque America Inc. Intravaginal Device Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bioteque America Inc. Intravaginal Device Product Portfolio
6.1.5 Bioteque America Inc. Recent Developments/Updates
6.2 Bray Group Limited.
6.2.1 Bray Group Limited. Company Information
6.2.2 Bray Group Limited. Description and Business Overview
6.2.3 Bray Group Limited. Intravaginal Device Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bray Group Limited. Intravaginal Device Product Portfolio
6.2.5 Bray Group Limited. Recent Developments/Updates
6.3 Gyneas
6.3.1 Gyneas Company Information
6.3.2 Gyneas Description and Business Overview
6.3.3 Gyneas Intravaginal Device Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Gyneas Intravaginal Device Product Portfolio
6.3.5 Gyneas Recent Developments/Updates
6.4 MedGyn Products, Inc.
6.4.1 MedGyn Products, Inc. Company Information
6.4.2 MedGyn Products, Inc. Description and Business Overview
6.4.3 MedGyn Products, Inc. Intravaginal Device Sales, Revenue and Gross Margin (2020-2025)
6.4.4 MedGyn Products, Inc. Intravaginal Device Product Portfolio
6.4.5 MedGyn Products, Inc. Recent Developments/Updates
6.5 Panpac Medical Corp.
6.5.1 Panpac Medical Corp. Company Information
6.5.2 Panpac Medical Corp. Description and Business Overview
6.5.3 Panpac Medical Corp. Intravaginal Device Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Panpac Medical Corp. Intravaginal Device Product Portfolio
6.5.5 Panpac Medical Corp. Recent Developments/Updates
6.6 Sugar International
6.6.1 Sugar International Company Information
6.6.2 Sugar International Description and Business Overview
6.6.3 Sugar International Intravaginal Device Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sugar International Intravaginal Device Product Portfolio
6.6.5 Sugar International Recent Developments/Updates
6.7 Thomas Medical
6.7.1 Thomas Medical Company Information
6.7.2 Thomas Medical Description and Business Overview
6.7.3 Thomas Medical Intravaginal Device Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Thomas Medical Intravaginal Device Product Portfolio
6.7.5 Thomas Medical Recent Developments/Updates
6.8 CooperSurgical Inc.
6.8.1 CooperSurgical Inc. Company Information
6.8.2 CooperSurgical Inc. Description and Business Overview
6.8.3 CooperSurgical Inc. Intravaginal Device Sales, Revenue and Gross Margin (2020-2025)
6.8.4 CooperSurgical Inc. Intravaginal Device Product Portfolio
6.8.5 CooperSurgical Inc. Recent Developments/Updates
6.9 Bayer AG
6.9.1 Bayer AG Company Information
6.9.2 Bayer AG Description and Business Overview
6.9.3 Bayer AG Intravaginal Device Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bayer AG Intravaginal Device Product Portfolio
6.9.5 Bayer AG Recent Developments/Updates
6.10 Merck & Co., Inc.
6.10.1 Merck & Co., Inc. Company Information
6.10.2 Merck & Co., Inc. Description and Business Overview
6.10.3 Merck & Co., Inc. Intravaginal Device Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Merck & Co., Inc. Intravaginal Device Product Portfolio
6.10.5 Merck & Co., Inc. Recent Developments/Updates
6.11 CIDR, LLC
6.11.1 CIDR, LLC Company Information
6.11.2 CIDR, LLC Description and Business Overview
6.11.3 CIDR, LLC Intravaginal Device Sales, Revenue and Gross Margin (2020-2025)
6.11.4 CIDR, LLC Intravaginal Device Product Portfolio
6.11.5 CIDR, LLC Recent Developments/Updates
6.12 AbbVie
6.12.1 AbbVie Company Information
6.12.2 AbbVie Description and Business Overview
6.12.3 AbbVie Intravaginal Device Sales, Revenue and Gross Margin (2020-2025)
6.12.4 AbbVie Intravaginal Device Product Portfolio
6.12.5 AbbVie Recent Developments/Updates
6.13 Medicines360
6.13.1 Medicines360 Company Information
6.13.2 Medicines360 Description and Business Overview
6.13.3 Medicines360 Intravaginal Device Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Medicines360 Intravaginal Device Product Portfolio
6.13.5 Medicines360 Recent Developments/Updates
6.14 Besins Healthcare
6.14.1 Besins Healthcare Company Information
6.14.2 Besins Healthcare Description and Business Overview
6.14.3 Besins Healthcare Intravaginal Device Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Besins Healthcare Intravaginal Device Product Portfolio
6.14.5 Besins Healthcare Recent Developments/Updates
6.15 ContraMed
6.15.1 ContraMed Company Information
6.15.2 ContraMed Description and Business Overview
6.15.3 ContraMed Intravaginal Device Sales, Revenue and Gross Margin (2020-2025)
6.15.4 ContraMed Intravaginal Device Product Portfolio
6.15.5 ContraMed Recent Developments/Updates
6.16 InControl Medical
6.16.1 InControl Medical Company Information
6.16.2 InControl Medical Description and Business Overview
6.16.3 InControl Medical Intravaginal Device Sales, Revenue and Gross Margin (2020-2025)
6.16.4 InControl Medical Intravaginal Device Product Portfolio
6.16.5 InControl Medical Recent Developments/Updates
6.17 INVO Bioscience
6.17.1 INVO Bioscience Company Information
6.17.2 INVO Bioscience Description and Business Overview
6.17.3 INVO Bioscience Intravaginal Device Sales, Revenue and Gross Margin (2020-2025)
6.17.4 INVO Bioscience Intravaginal Device Product Portfolio
6.17.5 INVO Bioscience Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravaginal Device Industry Chain Analysis
7.2 Intravaginal Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravaginal Device Production Mode & Process Analysis
7.4 Intravaginal Device Sales and 麻豆原创ing
7.4.1 Intravaginal Device Sales Channels
7.4.2 Intravaginal Device Distributors
7.5 Intravaginal Device Customer Analysis
8 Intravaginal Device 麻豆原创 Dynamics
8.1 Intravaginal Device Industry Trends
8.2 Intravaginal Device 麻豆原创 Drivers
8.3 Intravaginal Device 麻豆原创 Challenges
8.4 Intravaginal Device 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Bioteque America Inc.
Bray Group Limited.
Gyneas
MedGyn Products, Inc.
Panpac Medical Corp.
Sugar International
Thomas Medical
CooperSurgical Inc.
Bayer AG
Merck & Co., Inc.
CIDR, LLC
AbbVie
Medicines360
Besins Healthcare
ContraMed
InControl Medical
INVO Bioscience
听
听
*If Applicable.
